Insider filing · LLY
Ilya Yuffa
EVP&Pres, LLY USA&Global Capab
profile →
Eli Lilly and Company
LLY · Healthcare · 119 filings in 24 months
ticker →
Ilya Yuffa sold $2.9M of Eli Lilly and (LLY)
Executed Jun 10, disclosed Jun 11, 1 day later.
Value, as filed
$2.9M
2,500 sh × $1,150.77
Executed
Jun 10
the trade date, as filed
Disclosed
Jun 11
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
IYIlya Yuffa (EVP&Pres, LLY USA&Global Capab) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Eli Lilly and Company (LLY). The largest single filing was $2.9M of LLY (2,500 sh × $1,150.77, as filed), executed Jun 10.
The name
LLYHealthcare · Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Jap…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ilya Yuffa in LLY
LLYSALE
Eli Lilly and Company
$784K1,250 sh × $627.01
Exec Aug 11 2025
Filed Aug 12 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $937K
1,250 sh × $749.24
Exec May 14 2025
Filed May 15 2025 · 5:30 PM ET